Copyright Clearance Center

AUGUST 24, 2023

With new AI services being introduced on an almost daily basis, the adoption of FAIR Data Principles ( F indable, A ccessible, I nteroperable, and R eusable) is more important than ever. Speakers will address critical topics such as: The vital role of FAIR data in strategic AI initiatives.

Management 97

Management Media Training Leads 97

Rep-Lite

FEBRUARY 2, 2024

In medical sales, ongoing learning is invaluable as it ensures sales representatives stay abreast of industry advancements, new product developments, and evolving healthcare trends. Let’s discover some actionable tips on professional development in medical sales. Follow these tips: 1.

Medical sales 52

Medical sales Medical Sales Product Knowledge 52

Pharmaceutical Technology

FEBRUARY 16, 2023

The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. Under the deal, MD Anderson and Xilis aim to advance the development of drug and discovery projects using the MOS technology.

Pharmaceutical 96

Pharmaceutical Patients Medicine Leads 96

Pharmaceutical Technology

JANUARY 17, 2023

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development. Free Whitepaper.

Specialization 110

Specialization Patients Pharmaceutical Leads 110

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies.

Medicine 98

Medicine Food Leads Patients 98

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics and Eli Lilly and Company ’s wholly owned subsidiary Prevail Therapeutics have announced a partnership for the development of non-invasive gene therapies for central nervous system (CNS) diseases. Topic sponsors are not involved in the creation of editorial content.

Engineering 95

Engineering Leads Pharmaceutical Marketing 95

Pharmaceutical Technology

MARCH 28, 2023

Vertex Pharmaceuticals has signed a new non-exclusive licensing agreement with CRISPR Therapeutics to expedite the development of its hypoimmune cell therapies to treat type 1 diabetes (T1D). Topic sponsors are not involved in the creation of editorial content.

Pharmaceutical 94

Pharmaceutical Leads Marketing Patients 94

Pharmaceutical Technology

MAY 23, 2023

Avrobio will retain complete rights to its HSC gene therapies portfolio developed to treat Pompe disease, Gaucher disease type 1 and type 3, and Hunter syndrome. The company will also provide knowledge transfer and other related services to support the programme’s transition.

Food and Drug Administration 103

Food and Drug Administration Food Leads Pharmaceutical 103

Pharmaceutical Technology

DECEMBER 8, 2022

Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. Topic sponsors are not involved in the creation of editorial content. Subsequently, in the same year, Gilead Sciences acquired Kite. Free Whitepaper.

Manufacturing 122

Manufacturing Marketing Engineering Patients 122

Pharmaceutical Technology

FEBRUARY 9, 2023

The collaboration is aimed at discovering and developing new advanced treatments for genitourinary (GU) tumours as well as other related serious diseases using ReviR’s RNA-targeted technologies. Its initial focus is to develop therapeutics in oncology, CNS, and genetically defined disease indications.

Biopharma 96

Biopharma Pharmaceutical Patients Marketing 96

Pharmaceutical Technology

NOVEMBER 29, 2022

Neogene focuses on discovering, developing and producing next-generation T-cell receptor therapies (TCR-Ts) that provide a new cell therapy approach for fighting cancer. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Manufacturing 111

Manufacturing Leads Patients Pharmaceutical 111

Pharmaceutical Technology

DECEMBER 5, 2022

The hub will connect Queensland scientists with the teams at Sanofi’s mRNA Centre of Excellence in the US and France, putting them at the front of international vaccine development and biomedical research. In October, Sanofi and BioMed X signed a research partnership to utilise artificial intelligence (AI) for developing drugs.

Government 98

Government Pharmaceutical Marketing Leads 98

Pharmaceutical Technology

FEBRUARY 8, 2023

Genenta Science and AGC Biologics have signed a development and manufacturing service agreement (MSA). Genenta stated that the services offered under the existing deal are in addition to those offered under the agreement signed with AGC Biologics. Topic sponsors are not involved in the creation of editorial content.

Manufacturing 52

Manufacturing Pharmaceutical Medicine Management 52

Pharmaceutical Technology

JUNE 29, 2022

This comprises the co-development of core processes and production operations. GenCure will be able to offer a comprehensive solution for cell and gene therapy developers using the reference site. This will expand its portfolio for developers who need assistance with manufacturing and process optimisation.

Manufacturing 105

Manufacturing Management Pharmaceutical 105

pharmaphorum

OCTOBER 26, 2022

Topicals — creams, ointments, foams, and lotions applied directly to the affected areas of the skin — don’t get nearly as much TV time as their systemic biologic counterparts, the self-injectables with catchy theme songs, where the smiley and sleeveless walk confidently down the street and/or swim. Both are once-a-day treatments.

Side effects 89

Side effects Food and Drug Administration Patients Management 89

Contrarian Sales Techniques

MAY 1, 2023

A Booming Market with a Broader Scope The self-improvement industry is a massive and ever-growing market, providing an array of products and services aimed at helping individuals improve their personal and professional lives. These resources may include books, courses, workshops, coaching services, digital tools, and more.

Ethics 52

Ethics Marketing Government Management 52

Pharmaceutical Technology

DECEMBER 12, 2022

Gilead company Kite has entered an international strategic partnership with Arcellx for the joint development and commercialisation of the latter’s T-cell therapy, CART-ddBCMA, to treat relapsed or refractory multiple myeloma patients. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Manufacturing 105

Manufacturing Marketing Pharmaceutical Patients 105

Pharmaceutical Technology

MARCH 8, 2023

The multi-year collaboration aims to develop new technologies which will help in improving clinical outcomes for patients. The programme aims to develop advanced technologies and applications to improve human health. Topic sponsors are not involved in the creation of editorial content.

Food and Drug Administration 97

Food and Drug Administration Manufacturing Engineering Food 97

Pharmaceutical Technology

APRIL 17, 2023

Australian pharmaceutical company Incannex has appointed Quest Pharmaceutical Services (QPS) to advance CannQuit-N (Nicotine), CannQuit-O (Opioid) and Renecann Products in the USA and the European Union (EU). QPS was established in 1995 to provide bioanalytical LC-MS/MS contract services.

Food and Drug Administration 52

Food and Drug Administration Management Food Pharmaceutical 52

Clarivate

APRIL 21, 2022

In recent years, Ukraine has developed a reputation as an international information technology (IT) hub. According to Forbes magazine, the current aggressions from Russia have disrupted services from 70,000 – 100,000 highly qualified workers, including many with digital engineering and IT skills. Source: InCites. Source: InCites.

Engineering 98

Engineering Education Electronics Medicine 98

Rep-Lite

FEBRUARY 28, 2024

Certifications serve as tangible proof of expertise and commitment to professional development. Sales professionals gain a deeper understanding of complex topics like pharmacology, anatomy, physiology, disease pathology, and the latest advancements in medical technology. Looking to build your A-team in medical sales? Contact us now!

Medical sales 52

Medical sales Medical Sales Ethics 52

Pharmaceutical Technology

MAY 10, 2023

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. According to the US government, Gilead had repeatedly refused to license patents related to PrEP research undertaken by the Department of Health and Human Services’ (HHS) Centers for Disease Control and Prevention (CDC).

Government 105

Government FDA Pharmaceutical Pharma 105

Spotio

APRIL 30, 2024

It typically includes information about the products/services being sold, tips to analyze customer needs, proven negotiation and closing techniques, and more. It will also help them position your company’s products or services as the top solutions, which will build credibility in the marketplace. It makes sense.

Training 52

Training Manufacturing Sales Prospecting 52

Clarivate

MARCH 8, 2023

This could indicate that in the past decade, persistent challenges related to health equity and equal access to health services for historically exploited and rural women are drawing the attention of researchers. Exploring dissertations allows us insights into the topics researched by graduate students around the world.

Healthcare 98

Healthcare Healthcare Specialization Patients 98

Pharmaceutical Technology

DECEMBER 18, 2022

Topic sponsors are not involved in the creation of editorial content. Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer. Free Whitepaper.

Medicine 121

Medicine Marketing Pharmaceutical Leads 121

PharmaTech

SEPTEMBER 19, 2022

fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing, and fill/finish cGMP manufacturing for sterile injectable and topical products – all under one roof. Discovery the industry's best kept secret.a

Manufacturing 40

Manufacturing 40

Pharmaceutical Technology

DECEMBER 14, 2022

Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications. The firms intend to merge their expertise to provide simplified viral vector gene therapy development, production and testing in Japan. Free Whitepaper.

Manufacturing 52

Manufacturing Engineering Education Training 52

Pharmaceutical Technology

NOVEMBER 30, 2022

in a project agreement from the US government for developing self-amplifying RNA (saRNA) vaccine technology against advanced and emergent viral threats. Development of vaccines to Phase I trials under the five-year $59m prototype project comprises additional $28.4m Topic sponsors are not involved in the creation of editorial content.

Government 59

Government Medical Pharmaceutical Leads 59

Pharmaceutical Technology

JUNE 8, 2023

GenScript ProBio has collaborated with the New York Blood Center Enterprises’ business unit, called Comprehensive Cell Solutions (CCS), to accelerate the development and manufacture of cell and gene therapies. Topic sponsors are not involved in the creation of editorial content.

Manufacturing 52

Manufacturing Government Safety Pharmaceutical 52

Pharma Marketing Network

JULY 19, 2023

This is because the pharmaceutical industry is highly regulated, and businesses need to find creative ways to reach their target audience and educate them about their products and services. For example, a pharmaceutical company could create a blog post about a new drug that it is developing.

Marketing 98

Marketing Pharmaceutical Sales Education 98

Pharmaceutical Technology

FEBRUARY 23, 2023

Moderna has entered a strategic research and development partnership with ElevateBio’s Life Edit Therapeutics to discover and develop new in-vivo mRNA gene editing therapies. Moderna will also assume further development, manufacturing, and commercialisation responsibilities on exercising a target option.

Engineering 59

Engineering Pharmaceutical Manufacturing Medicine 59

Clarivate

DECEMBER 15, 2022

As we say goodbye to 2022 and look forward to the year ahead, it is a great opportunity to reflect on the topics we covered in our blog series on IP lifecycle management. Noel Young, Senior Product Development and Strategy Leader at Clarivate, covered 10 factors to consider when selecting an IP management system (IPMS) provider.

Management 52

Management Transportation Specialization Consulting 52

Clarify Health

SEPTEMBER 23, 2022

Across the 4-day conference, we heard sessions on topics ranging from service line marketing to current challenges with ASC data visibility to shifts in provider recruitment & retention trends. are 5-6x more likely to use other services from the same provider (such as primary care and maternity care).

Patients 52

Patients Recruitment Competition Physicians 52

Clarivate

JANUARY 23, 2024

R&D productivity fell in 2022, but late-phase cancellations are also trending down The rise and fall of R&D productivity across the global biopharmaceutical industry is a well-documented and much discussed topic, with industry commentators quantifying productivity in many ways (e.g., Learn more about purchasing it here.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Pharmaceutical Technology

JANUARY 12, 2023

Solid Biosciences has entered a strategic research collaboration with Phlox Therapeutics to expedite the development of new therapies for rare cardiac diseases. Under the research partnership deal, the companies will develop new precision genetic medicines for a severe form of genetic dilated cardiomyopathy (DCM). Free Whitepaper.

Manufacturing 52

Manufacturing Pharmaceutical Patients Medicine 52

Pharmaceutical Technology

AUGUST 22, 2022

Porton Advanced Solutions has raised $80m in a Series B funding round to expand its end-to-end gene and cell therapy (GCT) contract development and manufacturing organisation (CDMO) platforms. Topic sponsors are not involved in the creation of editorial content.

Manufacturing 52

Manufacturing Pharmaceutical Marketing Medicine 52

PharmaTech

AUGUST 31, 2022

fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing and fill/finish cGMP manufacturing for sterile injectable and topical products. Here what over 300 decision makers had to say about post-Covid trends - and also the discovery of the industry's best kept secret.a

Manufacturing 40

Manufacturing Marketing 40